Expression of transcription factor E2F1 induces quiescent cells to enter S phase View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-09

AUTHORS

David G. Johnson, James K. Schwarz, W. Douglas Cress, Joseph R. Nevins

ABSTRACT

SEVERAL lines of evidence implicate the E2F transcription factor as an important component of cell proliferation control. First, E2F binding sites are found in the promoters of genes responsive to proliferation signals and the level of E2F binding activity increases at a time when many of these genes are activated1–3. Second, the tumour suppressor protein Rb, as well as the related p107 protein, complexes with E2F2–7, resulting in an inhibition of E2F transcriptional activity3,8–12. Third, oncogenic products of the DNA tumour viruses can dissociate these E2F complexes4,13. We provide here direct evidence that E2F is involved in cellular proliferation control. Specifically, we demonstrate that overexpression of the E2F1 complementary DNA14,15 can activate DNA synthesis in cells that would otherwise growth-arrest, with an efficiency that is similar to that achieved by the expression of the adenovirus El A gene. Moreover, microinjection of the E2F1 cDNA into quiescent cells can induce S-phase entry, whereas two E2F1 mutants, which are unable to transactivate the DHFR and TK promoters, are unable to induce S phase. We conclude that the E2F transcription factor plays an important role in progression into S phase and that this probably coincides with its capacity to stimulate transcription. More... »

PAGES

349-352

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/365349a0

DOI

http://dx.doi.org/10.1038/365349a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043842059

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8377827


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenoviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bromodeoxyuridine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carrier Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Replication", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "E2F Transcription Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "E2F1 Transcription Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microinjections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinoblastoma Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinoblastoma-Binding Protein 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "S Phase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transfection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "beta-Galactosidase", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Johnson", 
        "givenName": "David G.", 
        "id": "sg:person.015535320757.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015535320757.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schwarz", 
        "givenName": "James K.", 
        "id": "sg:person.01362612356.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362612356.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cress", 
        "givenName": "W. Douglas", 
        "id": "sg:person.0720363323.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720363323.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nevins", 
        "givenName": "Joseph R.", 
        "id": "sg:person.01027714421.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027714421.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/358259a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020237383", 
          "https://doi.org/10.1038/358259a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/351494a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002431961", 
          "https://doi.org/10.1038/351494a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-09", 
    "datePublishedReg": "1993-09-01", 
    "description": "SEVERAL lines of evidence implicate the E2F transcription factor as an important component of cell proliferation control. First, E2F binding sites are found in the promoters of genes responsive to proliferation signals and the level of E2F binding activity increases at a time when many of these genes are activated1\u20133. Second, the tumour suppressor protein Rb, as well as the related p107 protein, complexes with E2F2\u20137, resulting in an inhibition of E2F transcriptional activity3,8\u201312. Third, oncogenic products of the DNA tumour viruses can dissociate these E2F complexes4,13. We provide here direct evidence that E2F is involved in cellular proliferation control. Specifically, we demonstrate that overexpression of the E2F1 complementary DNA14,15 can activate DNA synthesis in cells that would otherwise growth-arrest, with an efficiency that is similar to that achieved by the expression of the adenovirus El A gene. Moreover, microinjection of the E2F1 cDNA into quiescent cells can induce S-phase entry, whereas two E2F1 mutants, which are unable to transactivate the DHFR and TK promoters, are unable to induce S phase. We conclude that the E2F transcription factor plays an important role in progression into S phase and that this probably coincides with its capacity to stimulate transcription.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/365349a0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6444", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "365"
      }
    ], 
    "keywords": [
      "E2F transcription factors", 
      "transcription factors", 
      "proliferation control", 
      "related p107 protein", 
      "quiescent cells", 
      "levels of E2F", 
      "promoters of genes", 
      "E2F binding sites", 
      "cellular proliferation control", 
      "cell proliferation control", 
      "transcription factor E2F1", 
      "tumor suppressor protein", 
      "inhibition of E2F", 
      "DNA tumor viruses", 
      "E2F1 cDNA", 
      "p107 protein", 
      "adenovirus El", 
      "suppressor protein", 
      "phase entry", 
      "E2F", 
      "TK promoter", 
      "proliferation signals", 
      "lines of evidence", 
      "genes", 
      "tumor virus", 
      "DNA synthesis", 
      "binding sites", 
      "oncogenic products", 
      "promoter", 
      "protein", 
      "cells", 
      "expression", 
      "direct evidence", 
      "important role", 
      "mutants", 
      "transcription", 
      "E2F1", 
      "cDNA", 
      "activity increases", 
      "important component", 
      "overexpression", 
      "DHFR", 
      "complexes", 
      "microinjection", 
      "inhibition", 
      "sites", 
      "virus", 
      "evidence", 
      "role", 
      "lines", 
      "progression", 
      "factors", 
      "entry", 
      "synthesis", 
      "signals", 
      "control", 
      "components", 
      "levels", 
      "products", 
      "capacity", 
      "increase", 
      "Complementary", 
      "phase", 
      "efficiency", 
      "time", 
      "EL", 
      "activated1\u20133", 
      "E2F2\u20137", 
      "E2F1 complementary", 
      "factor E2F1"
    ], 
    "name": "Expression of transcription factor E2F1 induces quiescent cells to enter S phase", 
    "pagination": "349-352", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043842059"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/365349a0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8377827"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/365349a0", 
      "https://app.dimensions.ai/details/publication/pub.1043842059"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_225.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/365349a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/365349a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/365349a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/365349a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/365349a0'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      22 PREDICATES      117 URIs      107 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/365349a0 schema:about N04bcb788c267472099fa5ca516a14164
2 N092e2c1b394c4306b9fdc07feff24287
3 N207eabbad16744a2a42556a23372debc
4 N229f52386faf4703b658ee4aceb9a473
5 N3fd1a544e5e04773a6c9c35f9cf86b05
6 N5aebed0430fe4635b83133175dfe44fb
7 N5bedb02318ab4e8db852446523d4fb66
8 N6615e720b47c41bbb31851673648aef0
9 N6a91b152b5bf40d9a8d2c826e3f94f65
10 N6d50e32b23de4a3e9607be28a83a0d07
11 N7523822ed707463690d9a4cf601aa337
12 N7f9ee424e42545b7ae4c1254d89890a5
13 N8dca54848f024c5083e5b6420edaee2f
14 N98bfee8d62574830896d2e66431bb7be
15 Nc42f88de71ab4ff79c5752cdebf2ba41
16 Nc9ae3f7035664d6bad4956e2892e71bd
17 Nd7ec2ed078f9400abddbf5e77810d474
18 Nd90a9ee1350147958e0142a207abe7f6
19 anzsrc-for:06
20 anzsrc-for:0601
21 schema:author N8b00aacba21744d69f3867f4ba0668e3
22 schema:citation sg:pub.10.1038/351494a0
23 sg:pub.10.1038/358259a0
24 schema:datePublished 1993-09
25 schema:datePublishedReg 1993-09-01
26 schema:description SEVERAL lines of evidence implicate the E2F transcription factor as an important component of cell proliferation control. First, E2F binding sites are found in the promoters of genes responsive to proliferation signals and the level of E2F binding activity increases at a time when many of these genes are activated1–3. Second, the tumour suppressor protein Rb, as well as the related p107 protein, complexes with E2F2–7, resulting in an inhibition of E2F transcriptional activity3,8–12. Third, oncogenic products of the DNA tumour viruses can dissociate these E2F complexes4,13. We provide here direct evidence that E2F is involved in cellular proliferation control. Specifically, we demonstrate that overexpression of the E2F1 complementary DNA14,15 can activate DNA synthesis in cells that would otherwise growth-arrest, with an efficiency that is similar to that achieved by the expression of the adenovirus El A gene. Moreover, microinjection of the E2F1 cDNA into quiescent cells can induce S-phase entry, whereas two E2F1 mutants, which are unable to transactivate the DHFR and TK promoters, are unable to induce S phase. We conclude that the E2F transcription factor plays an important role in progression into S phase and that this probably coincides with its capacity to stimulate transcription.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N4c9fa99c2c5d4d5cafee39da637b8d73
31 N6b37963c45be4f36bc898f8c43d1a924
32 sg:journal.1018957
33 schema:keywords Complementary
34 DHFR
35 DNA synthesis
36 DNA tumor viruses
37 E2F
38 E2F binding sites
39 E2F transcription factors
40 E2F1
41 E2F1 cDNA
42 E2F1 complementary
43 E2F2–7
44 EL
45 TK promoter
46 activated1–3
47 activity increases
48 adenovirus El
49 binding sites
50 cDNA
51 capacity
52 cell proliferation control
53 cells
54 cellular proliferation control
55 complexes
56 components
57 control
58 direct evidence
59 efficiency
60 entry
61 evidence
62 expression
63 factor E2F1
64 factors
65 genes
66 important component
67 important role
68 increase
69 inhibition
70 inhibition of E2F
71 levels
72 levels of E2F
73 lines
74 lines of evidence
75 microinjection
76 mutants
77 oncogenic products
78 overexpression
79 p107 protein
80 phase
81 phase entry
82 products
83 progression
84 proliferation control
85 proliferation signals
86 promoter
87 promoters of genes
88 protein
89 quiescent cells
90 related p107 protein
91 role
92 signals
93 sites
94 suppressor protein
95 synthesis
96 time
97 transcription
98 transcription factor E2F1
99 transcription factors
100 tumor suppressor protein
101 tumor virus
102 virus
103 schema:name Expression of transcription factor E2F1 induces quiescent cells to enter S phase
104 schema:pagination 349-352
105 schema:productId N5ab87295442343749edf81c176ecbaba
106 Nb9c016deae4b4f00abf2d319b1ffb8b2
107 Ne1aec390d457477186efcf8ce0dfa458
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043842059
109 https://doi.org/10.1038/365349a0
110 schema:sdDatePublished 2022-01-01T18:05
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher Nbb89969814f5423da98b6c8370b30555
113 schema:url https://doi.org/10.1038/365349a0
114 sgo:license sg:explorer/license/
115 sgo:sdDataset articles
116 rdf:type schema:ScholarlyArticle
117 N04bcb788c267472099fa5ca516a14164 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Transfection
119 rdf:type schema:DefinedTerm
120 N092e2c1b394c4306b9fdc07feff24287 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name beta-Galactosidase
122 rdf:type schema:DefinedTerm
123 N207eabbad16744a2a42556a23372debc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Bromodeoxyuridine
125 rdf:type schema:DefinedTerm
126 N229f52386faf4703b658ee4aceb9a473 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Retinoblastoma-Binding Protein 1
128 rdf:type schema:DefinedTerm
129 N3fd1a544e5e04773a6c9c35f9cf86b05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name E2F1 Transcription Factor
131 rdf:type schema:DefinedTerm
132 N4c9fa99c2c5d4d5cafee39da637b8d73 schema:issueNumber 6444
133 rdf:type schema:PublicationIssue
134 N5ab87295442343749edf81c176ecbaba schema:name doi
135 schema:value 10.1038/365349a0
136 rdf:type schema:PropertyValue
137 N5aebed0430fe4635b83133175dfe44fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name DNA
139 rdf:type schema:DefinedTerm
140 N5bedb02318ab4e8db852446523d4fb66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Cell Cycle Proteins
142 rdf:type schema:DefinedTerm
143 N6264331073db4eda959b6516c82a5904 rdf:first sg:person.01027714421.70
144 rdf:rest rdf:nil
145 N6615e720b47c41bbb31851673648aef0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name S Phase
147 rdf:type schema:DefinedTerm
148 N6a91b152b5bf40d9a8d2c826e3f94f65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Retinoblastoma Protein
150 rdf:type schema:DefinedTerm
151 N6b37963c45be4f36bc898f8c43d1a924 schema:volumeNumber 365
152 rdf:type schema:PublicationVolume
153 N6d50e32b23de4a3e9607be28a83a0d07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name E2F Transcription Factors
155 rdf:type schema:DefinedTerm
156 N7523822ed707463690d9a4cf601aa337 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Transcription, Genetic
158 rdf:type schema:DefinedTerm
159 N7f9ee424e42545b7ae4c1254d89890a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Cell Line
161 rdf:type schema:DefinedTerm
162 N8b00aacba21744d69f3867f4ba0668e3 rdf:first sg:person.015535320757.02
163 rdf:rest Na1f309bcc3dd433d82e435e30218b283
164 N8dca54848f024c5083e5b6420edaee2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Carrier Proteins
166 rdf:type schema:DefinedTerm
167 N98bfee8d62574830896d2e66431bb7be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Transcription Factors
169 rdf:type schema:DefinedTerm
170 Na1f309bcc3dd433d82e435e30218b283 rdf:first sg:person.01362612356.48
171 rdf:rest Neaf179a686c542618f29ffdd6df7ccc4
172 Nb9c016deae4b4f00abf2d319b1ffb8b2 schema:name pubmed_id
173 schema:value 8377827
174 rdf:type schema:PropertyValue
175 Nbb89969814f5423da98b6c8370b30555 schema:name Springer Nature - SN SciGraph project
176 rdf:type schema:Organization
177 Nc42f88de71ab4ff79c5752cdebf2ba41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Adenoviridae
179 rdf:type schema:DefinedTerm
180 Nc9ae3f7035664d6bad4956e2892e71bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name DNA Replication
182 rdf:type schema:DefinedTerm
183 Nd7ec2ed078f9400abddbf5e77810d474 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Microinjections
185 rdf:type schema:DefinedTerm
186 Nd90a9ee1350147958e0142a207abe7f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name DNA-Binding Proteins
188 rdf:type schema:DefinedTerm
189 Ne1aec390d457477186efcf8ce0dfa458 schema:name dimensions_id
190 schema:value pub.1043842059
191 rdf:type schema:PropertyValue
192 Neaf179a686c542618f29ffdd6df7ccc4 rdf:first sg:person.0720363323.02
193 rdf:rest N6264331073db4eda959b6516c82a5904
194 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
195 schema:name Biological Sciences
196 rdf:type schema:DefinedTerm
197 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
198 schema:name Biochemistry and Cell Biology
199 rdf:type schema:DefinedTerm
200 sg:journal.1018957 schema:issn 0028-0836
201 1476-4687
202 schema:name Nature
203 schema:publisher Springer Nature
204 rdf:type schema:Periodical
205 sg:person.01027714421.70 schema:affiliation grid-institutes:grid.189509.c
206 schema:familyName Nevins
207 schema:givenName Joseph R.
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027714421.70
209 rdf:type schema:Person
210 sg:person.01362612356.48 schema:affiliation grid-institutes:grid.189509.c
211 schema:familyName Schwarz
212 schema:givenName James K.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362612356.48
214 rdf:type schema:Person
215 sg:person.015535320757.02 schema:affiliation grid-institutes:grid.189509.c
216 schema:familyName Johnson
217 schema:givenName David G.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015535320757.02
219 rdf:type schema:Person
220 sg:person.0720363323.02 schema:affiliation grid-institutes:grid.189509.c
221 schema:familyName Cress
222 schema:givenName W. Douglas
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720363323.02
224 rdf:type schema:Person
225 sg:pub.10.1038/351494a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002431961
226 https://doi.org/10.1038/351494a0
227 rdf:type schema:CreativeWork
228 sg:pub.10.1038/358259a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020237383
229 https://doi.org/10.1038/358259a0
230 rdf:type schema:CreativeWork
231 grid-institutes:grid.189509.c schema:alternateName Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA
232 schema:name Section of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, PO Box 3054, 27710, Durham, North Carolina, USA
233 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...